A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients with Huntington's Disease.

Project: Research

Project Details

StatusActive
Effective start/end date18/09/1931/10/21

Keywords

  • Neurology
  • Huntington's disease
  • Clinical trial